STOCK TITAN

If You Invested in Bespoke Extracts Inc (BSPK)

Healthcare · Drug Manufacturers - Specialty & Generic · OTC
See the BSPK overview
BSPK has not traded since Oct 8, 2026. Its last close was $0.0005, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
$1.56
-99.8% price return -99.8% CAGR
-99.8% with dividends reinvested
Bought on Oct 8, 2025 at $0.3198 split-adjusted
$1,000 invested 5 Years Before Its Last Close
$0.72
-99.9% price return -76.5% CAGR
-99.9% with dividends reinvested
Bought on Oct 8, 2021 at $0.6953 split-adjusted

What $1,000 or $10,000 in BSPK Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Nov 9, 2015
$1,000 $1.56 -99.84% $0.72 -99.93% $0.04 -99.99% $0.01 -99.99%
$10,000 $16 -99.84% $7.19 -99.93% $0.44 -99.99% $0.12 -99.99%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-08. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for BSPK

$1,000 Investment Over Time

BSPK vs S&P 500

Year-by-Year Returns

BSPK annual performance
Year Start Price End Price Annual Return Cumulative
2015Nov 9, 2015 to Dec 31, 2015 $40.50 $14.85 -63.3% -63.3%
2016 $14.85 $6.75 -54.5% -83.3%
2017 $6.75 $22.95 +240.0% -43.3%
2018 $22.95 $2.39 -89.6% -94.1%
2019 $2.39 $0.45 -81.1% -98.9%
2020 $0.45 $0.9450 +110.0% -97.7%
2021 $0.9450 $1.2150 +28.6% -97.0%
2022 $1.2150 $0.2025 -83.3% -99.5%
2023 $0.2025 $0.0355 -82.5% -99.9%
2024 $0.0355 $0.0608 +71.3% -99.8%
2025Dec 31, 2024 to Dec 22, 2025 $0.0608 $0.20 +228.9% -99.5%
2026Dec 22, 2025 to Oct 8, 2026 $0.20 $0.0005 -99.8% -99.99%

About Bespoke Extracts Inc

Healthcare · OTC

Bespoke Extracts, Inc. (OTCQB: BSPK), operating as The Joint Company, is a Colorado-based business focused on the regulated cannabis market in the United States. According to company disclosures and press releases, Bespoke centers its operations on the production of branded and white-label pre-rolled cannabis joints and related processing services for licensed dispensaries in Colorado. The company reports that its Colorado business has been rebranded under The Joint Company and emphasizes disciplined execution, brand development, and manufacturing efficiency in a competitive cannabis environment.

Core Operations and Business Focus

Through its subsidiary Bespoke Extracts Colorado, LLC, the company operates a marijuana-infused products manufacturing facility in Aurora, Colorado. Bespoke states that this facility produces pre-rolled joints and provides joint production and processing services to licensed dispensaries in the state. The company reports that direct sales of branded pre-rolled joints and expanded joint production services are key drivers of its revenue. Bespoke highlights its focus on cost efficiencies in raw materials, packaging, and labor, which it links to improvements in gross margins over time.

Bespoke has described its Colorado operations as a platform for The Joint Company brand, under which it has developed a portfolio of pre-roll products. The company reports that it produces high volumes of pre-rolls and that production growth has been an important element of its strategy. It has also indicated that it serves third-party clients through processing arrangements, contributing to additional revenue streams within the regulated cannabis market.

Brands and Product Lines

In its public communications, Bespoke identifies several branded pre-roll product lines under The Joint Company umbrella. The company describes Fresh Joints as its core brand and notes that this line has shown continued year-over-year growth and meaningful contribution to product revenue. Bespoke also reports the launch and growth of two additional brands, Doobskis and Dutch Blunts, which it states have achieved market penetration and traction with retail partners in Colorado.

According to management commentary, these brands are positioned within Colorado’s regulated cannabis market, with Fresh Joints highlighted for quality and volume growth in the pre-roll category. The company has described itself as a multi-brand pre-roll house within Colorado, with each brand contributing to a diversified pre-roll offering. Bespoke also notes that it has a third-party processing business that has experienced growth, driven by new client contracts.

Strategic Rebranding and Evolution

Bespoke reports that in the first quarter of 2025 it completed a strategic rebranding of its product offerings under The Joint Company (TJC). This rebranding is described as a pivotal step in its growth strategy, aligning its Colorado manufacturing and brand portfolio under a unified identity. The company indicates that TJC scaled its white-label processing business and launched the Doobskis and Dutch Blunts brands as part of this transition, while continuing to grow the Fresh Joints line.

Earlier company communications show that Bespoke’s history includes activity in hemp-derived CBD products and consumer products in CBD and regulated cannabis. Prior press releases describe Bespoke as a producer of high quality, hemp-derived CBD products and as a company focusing on consumer products in regulated cannabis and CBD. Over time, the company’s disclosures emphasize a shift toward regulated cannabis operations in Colorado, including infused products manufacturing and pre-roll production.

Regulated Cannabis Market Positioning

Bespoke’s public statements describe its strategy as focused on operating within state-regulated cannabis markets, beginning with Colorado. The company has reported efforts to expand its Colorado presence through acquisitions and regulatory approvals. For example, it announced signing definitive documents to acquire the assets of Wonderleaf, LLC, a licensed marijuana-infused products manufacturer in Denver, Colorado, which it described as marking its entry into the regulated cannabis business. Bespoke also announced a definitive agreement to acquire the assets of Osiris, LLC doing business as Best Day Ever, a vertically integrated Colorado cannabis licensee with cultivation and retail operations in Aspen and Glenwood Springs, Colorado.

The company has further disclosed that the Colorado Marijuana Enforcement Division granted it Suitability approval, enabling Bespoke to acquire businesses licensed by the MED, subject to final state and local approvals. Bespoke has characterized these regulatory milestones and proposed acquisitions as important components of its Colorado growth plans, including potential vertical integration and expanded capabilities in cultivation, retail, and infused products.

Manufacturing, Efficiency, and Operations

In multiple financial results releases, Bespoke highlights operational metrics related to pre-roll production and manufacturing efficiency. The company reports producing record numbers of pre-rolls in successive quarters and links higher production volumes to revenue growth. It also emphasizes improvements in gross margin, which it attributes to efficiencies in materials, labor, and packaging, as well as enhanced manufacturing processes.

Management commentary describes the company’s approach as focused on process improvements, data-driven iteration, and cost management. Bespoke notes that it has achieved cost efficiencies while also investing in marketing, sampling for new product launches, and customer acquisition. The company presents these operational changes as evidence of its ability to scale pre-roll production and support both its own brands and third-party processing clients.

Capital Markets and Corporate Status

Bespoke Extracts, Inc. is incorporated in Nevada, as reflected in its SEC filings. The company’s common stock trades on the OTCQB Venture Market under the symbol BSPK. Bespoke has stated that its uplisting from the OTC Pink Open Market to the OTCQB was intended to increase visibility and enhance trading liquidity, while also reflecting its focus on compliance and financial reporting.

The company has also disclosed capital-raising activities, including a private placement of common stock to an accredited investor, which it stated would be used for working capital purposes. In an 8-K filing, Bespoke reported entering into an amendment to a senior note with a principal amount of $849,500, extending the maturity date while keeping other material terms in place. These disclosures provide context on the company’s financing arrangements and obligations.

Regulatory Filings and Reporting

Bespoke files periodic reports and current reports with the U.S. Securities and Exchange Commission. The company has furnished press releases announcing quarterly financial results via Form 8-K, including results for the quarters ended March 31, June 30, and September 30, 2025. These filings include consolidated balance sheets and statements of operations that detail revenue, cost of products sold, operating expenses, interest expense, and net loss, as well as information on assets, liabilities, and stockholders’ deficit.

In its filings, Bespoke identifies itself as an emerging growth company and notes that it has elected certain reporting accommodations available under applicable securities laws. The company’s disclosures emphasize that its financial results are prepared in accordance with U.S. generally accepted accounting principles (GAAP) and that its SEC filings contain additional detail on its financial condition and results of operations.

Historical CBD and Brand Activities

Prior to its current emphasis on The Joint Company and Colorado pre-roll manufacturing, Bespoke publicly described itself as a producer of high quality, hemp-derived CBD products. Company communications from that period highlight a focus on tailoring CBD experiences for health and wellness-minded consumers, using hemp sourced from NSF-certified and USDA-certified organic producers in the United States, and employing industry-standard extraction methods.

Bespoke also disclosed marketing initiatives such as teaming with LEAF411, a nonprofit cannabis-trained nurse hotline, to provide customers with educational resources on the safe use of hemp-derived CBD products. The company announced brand ambassador relationships, including with professional mixed martial artist Mike “Platinum” Perry, to promote its CBD formulations. These historical activities illustrate the company’s earlier positioning in the CBD consumer products space before its strategic emphasis on regulated cannabis operations in Colorado.

Geographic Focus

Based on its public disclosures, Bespoke’s operational focus is centered on Colorado. The company identifies Aurora, Colorado as the location of its marijuana-infused products manufacturing facility and references Denver, Aspen, and Glenwood Springs, Colorado in connection with proposed acquisitions and existing or planned facilities. Bespoke has also stated that it is exploring potential expansion of The Joint Company model into other state-regulated cannabis markets, mentioning Massachusetts and New York as examples of markets under evaluation.

Risk and Regulatory Considerations

Bespoke’s press releases include cautionary language regarding forward-looking statements and note that its operations are subject to regulatory approvals and oversight in the jurisdictions where it operates. The company’s proposed acquisitions in Colorado are described as contingent on approvals from state and local regulatory agencies and on satisfaction of customary closing conditions. Its financial disclosures also reflect the risks associated with operating in a regulated cannabis market, including market contractions and competitive pressures in Colorado.

Summary

According to its public statements and SEC filings, Bespoke Extracts, Inc. has evolved from a hemp-derived CBD products company into a Colorado-focused regulated cannabis operator, with a particular emphasis on pre-rolled joints and processing services under The Joint Company brand. Its business model centers on manufacturing, branding, and processing within state-regulated cannabis markets, with Colorado serving as its primary operating base and proving ground for potential expansion into additional markets.

Market Cap
$0.0B
Last Close
$0.0005
EPS (FY2024)
-$0.10
Revenue (FY2024)
$0.0B
Net Margin (FY2024)
-92.8%
View full BSPK overview

Frequently Asked Questions

Bespoke Extracts Inc investment returns

How much was $1,000 invested in Bespoke Extracts Inc worth at its last close?

If you invested $1,000 in Bespoke Extracts Inc (BSPK) 10 years before its last close, on 2016-10-10, your investment was worth $0.04 on 2026-10-08, a -99.99% price return without dividends, growing at a compounded rate of -63.3% per year (CAGR).

Has Bespoke Extracts Inc outperformed the S&P 500?

In the 10 years to Oct 8, 2026, BSPK returned -99.99% compared to +258.0% for the S&P 500, underperforming the benchmark by 358.0 percentage points.

What is Bespoke Extracts Inc's average annual return?

The compound annual growth rate (CAGR) of BSPK’s share price over the 10 years to Oct 8, 2026 is -63.3%, without dividends. Individual years vary a great deal, and BSPK’s best recent full year was 2017 (+240.0%) while the worst was 2018 (-89.6%).

For informational and educational purposes only, not investment advice.